Blood Biomarker Shows Promise Predicting Progression to Alzheimer’s
Researchers confirmed the usefulness of NfL blood levels to predict the likelihood of progression of neurodegeneration in Alzheimer’s.
Researchers confirmed the usefulness of NfL blood levels to predict the likelihood of progression of neurodegeneration in Alzheimer’s.
Approximately 80% of older adults haven’t had a cognitive test in the past year to look for signs of Alzheimer’s or other types of dementia.
It is estimated that one in 10 elderly Americans have Alzheimer’s Disease. A new test may aid in making it a manageable condition.
Measuring a key blood molecule may help diagnose whether or how much impaired blood flow to a patient’s brain is contributing to dementia.
Read MoreA new study indicates that 90% of physicians would use the results of the DISCERN test to more accurately diagnose Alzheimer’s.
Read MoreA noninvasive, focused-ultrasound-mediated liquid biopsy could help facilitate diagnosis of neurodegenerative disorders.
Read MoreResearchers established a blood test that may predict the risk of Alzheimer’s disease up to three and half years before clinical diagnosis.
Read MoreNew data suggests that over half of symptomatic Alzheimer’s patients are misdiagnosed for the disease in the primary care setting.
Read MoreResearchers are developing a new biosensor that can be used to screen for Alzheimer’s disease and other diseases early.
Read MoreA smart intraocular lens that can be inserted into the eye to diagnose Alzheimer’s has been developed in Korea.
Read MoreA U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read MoreA new study on an inherited form of Alzheimer’s shows that the GFAP protein is a possible biomarker for very early stages of the disease.
Read MoreDiadem SpA presented clinical data highlighting the accuracy and utility of its AlzoSure Predict prognostic blood test for Alzheimer’s.
Read MoreResearchers have developed a blood biomarker test to detect a novel marker of Alzheimer’s disease neurodegeneration in a blood sample.
Read MoreA recent study revealed that low levels of ergothioneine in blood plasma may predict an increased risk of cognitive impairment and dementia.
Read MoreResearchers have discovered a correlation between Piwi-interacting RNA and brain inflammation, which will lead to new diagnostic techniques.
Read MoreA start-up company received federal support to develop a new technology that can be used for early diagnosis of Alzheimer’s disease.
Read MoreRoche’s Elecsys beta-Amyloid CSF II and Elecsys Phospho-Tau CSF assays received U.S. FDA 510(k) clearance to evaluate Alzheimer’s
Read More